Literature DB >> 18540978

Nerve growth factor receptor (p75 NTR) and pattern of invasion predict poor prognosis in oral squamous cell carcinoma.

T M Søland1, I J Brusevold, H S Koppang, K Schenck, M Bryne.   

Abstract

AIMS: To evaluate the expression of p75 neurotrophin receptor (p75(NTR)) in oral squamous cell carcinoma (OSCC). The results were related to tumour node metastasis (TNM) stage, World Health Organization (WHO) grade, invasive front grading (IFG) and prognosis. METHODS AND
RESULTS: Immunohistochemically, the expression of p75(NTR) was assessed in 53 T1-T2 OSCCs. Clinical data were recorded prospectively. The end-point was disease-free survival. All tumours expressed p75(NTR), and this expression, both in central/superficial tumour areas and at the invasive front, was associated with poor prognosis (P = 0.03 and P = 0.02) (log rank test). Tumours with marked cellular dissociation (IFG parameter) had more recurrences than tumours with collective tumour cell invasion (P = 0.03). In tumours showing both p75(NTR) at the invasive front and marked tumour cell dissociation, the average risk of recurrence was increased about 17 times (Cox regression analysis) compared with tumours with low p75(NTR) expression and collective invasion. Traditional prognostic systems were of no prognostic significance.
CONCLUSION: p75(NTR) was expressed in all OSCCs. p75(NTR) expression and the pattern of invasion were significantly associated with a poor prognosis in OSCCs, and both were better prognostic factors than traditional prognostic parameters. The combination of p75(NTR) expression and the pattern of invasion strongly increased precision in the identification of tumours with poor disease-free survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18540978     DOI: 10.1111/j.1365-2559.2008.03063.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  20 in total

Review 1.  Role of p75 neurotrophin receptor in stem cell biology: more than just a marker.

Authors:  Elisa Tomellini; Chann Lagadec; Renata Polakowska; Xuefen Le Bourhis
Journal:  Cell Mol Life Sci       Date:  2014-01-31       Impact factor: 9.261

2.  Gene Expression Signatures of Lymph Node Metastasis in Oral Cancer: Molecular Characteristics and Clinical Significances.

Authors:  Xiqiang Liu; Antonia Kolokythas; Jianguang Wang; Hongzhang Huang; Xiaofeng Zhou
Journal:  Curr Cancer Ther Rev       Date:  2010-11-01

3.  CD271 Confers an Invasive and Metastatic Phenotype of Head and Neck Squamous Cell Carcinoma through the Upregulation of Slug.

Authors:  Man Ki Chung; Young Ho Jung; Joon Kyoo Lee; Soo Youn Cho; Oihana Murillo-Sauca; Ravindra Uppaluri; June Ho Shin; John B Sunwoo
Journal:  Clin Cancer Res       Date:  2017-12-05       Impact factor: 12.531

4.  Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.

Authors:  Osama A Elkashty; Ghada Abu Elghanam; Xinyun Su; Younan Liu; Peter J Chauvin; Simon D Tran
Journal:  Carcinogenesis       Date:  2020-06-17       Impact factor: 4.944

5.  Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma.

Authors:  Takahiro Kiyosue; Shintaro Kawano; Ryota Matsubara; Yuichi Goto; Mitsuhiro Hirano; Teppei Jinno; Takeshi Toyoshima; Ryoji Kitamura; Kazunari Oobu; Seiji Nakamura
Journal:  Int J Clin Oncol       Date:  2011-12-15       Impact factor: 3.402

6.  Expression of cancer stem cell markers CD44, ALDH1 and p75NTR in actinic cheilitis and lip cancer.

Authors:  Marcos Custódio; Cibele Pelissari; Thalita Santana; Marília Trierveiler
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-05-19       Impact factor: 2.503

7.  CD271 defines a stem cell-like population in hypopharyngeal cancer.

Authors:  Takayuki Imai; Keiichi Tamai; Sayuri Oizumi; Kyoko Oyama; Kazunori Yamaguchi; Ikuro Sato; Kennichi Satoh; Kazuto Matsuura; Shigeru Saijo; Kazuo Sugamura; Nobuyuki Tanaka
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

8.  Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinoma.

Authors:  Liana Cristina Melo Carneiro Costa; Camila Ferreira Leite; Sérgio Vitorino Cardoso; Adriano Mota Loyola; Paulo Rogério de Faria; Paulo Eduardo Alencar Souza; Martinho Campolina Rebello Horta
Journal:  J Appl Oral Sci       Date:  2015 Mar-Apr       Impact factor: 2.698

9.  CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma.

Authors:  Oihana Murillo-Sauca; Man Ki Chung; June Ho Shin; Christina Karamboulas; Shirley Kwok; Young Ho Jung; Richard Oakley; James R Tysome; Lovisa O Farnebo; Michael J Kaplan; Davud Sirjani; Vasu Divi; F Christopher Holsinger; Chafeek Tomeh; Anthony Nichols; Quynh T Le; A Dimitrios Colevas; Christina S Kong; Ravindra Uppaluri; James S Lewis; Laurie E Ailles; John B Sunwoo
Journal:  Oncotarget       Date:  2014-08-30

10.  The translational significance of epithelial-mesenchymal transition in head and neck cancer.

Authors:  Christian A Graves; Fadi F Abboodi; Swati Tomar; James Wells; Lucia Pirisi
Journal:  Clin Transl Med       Date:  2014-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.